Overview

Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Healthy Male Subjects

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Safety and tolerability and Pharmacokinetics of multiple doses of BV100 in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
BioVersys SAS
Collaborator:
Nuvisan GmbH